User profiles for Davor Pavlovic
Davor PavlovicAssociate Professor of Cardiovascular Science, University of Birmingham Verified email at bham.ac.uk Cited by 2791 |
The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives
D Pavlović, DCA Neville, O Argaud… - Proceedings of the …, 2003 - National Acad Sciences
We show that hepatitis C virus (HCV) p7 protein forms ion channels in black lipid membranes.
HCV p7 ion channels are inhibited by long-alkyl-chain iminosugar derivatives, which have …
HCV p7 ion channels are inhibited by long-alkyl-chain iminosugar derivatives, which have …
A simplified, Langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart
…, PY Li, AP Holmes, SM O'Brien, D Pavlovic… - Circulation …, 2016 - Am Heart Assoc
Rationale: Cardiovascular disease represents a global pandemic. The advent of and recent
advances in mouse genomics, epigenomics, and transgenics offer ever-greater potential for …
advances in mouse genomics, epigenomics, and transgenics offer ever-greater potential for …
Na+/Ca2+ exchange and Na+/K+‐ATPase in the heart
…, J Kaplan, JB Lingrel, D Pavlovic… - The Journal of …, 2015 - Wiley Online Library
This paper is the third in a series of reviews published in this issue resulting from the
University of California Davis Cardiovascular Symposium 2014: Systems approach to …
University of California Davis Cardiovascular Symposium 2014: Systems approach to …
Complex relationship between cardiac fibroblasts and cardiomyocytes in health and disease
Cardiac fibroblasts are the primary cell type responsible for deposition of extracellular matrix
in the heart, providing support to the contracting myocardium and contributing to a myriad of …
in the heart, providing support to the contracting myocardium and contributing to a myriad of …
Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart
Aims Emipagliflozin (EMPA) is a potent inhibitor of the renal sodium-glucose co-transporter
2 (SGLT2) and an effective treatment for type-2 diabetes. In patients with diabetes and heart …
2 (SGLT2) and an effective treatment for type-2 diabetes. In patients with diabetes and heart …
[HTML][HTML] Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations
Chronic kidney disease (CKD) is a complex condition with a prevalence of 10–15% worldwide.
An inverse-graded relationship exists between cardiovascular events and mortality with …
An inverse-graded relationship exists between cardiovascular events and mortality with …
PITX2 Modulates Atrial Membrane Potential and the Antiarrhythmic Effects of Sodium-Channel Blockers
…, TY Yu, S Tull, SM Kuhlmann, D Pavlovic… - Journal of the American …, 2016 - jacc.org
Background : Antiarrhythmic drugs are widely used to treat patients with atrial fibrillation (AF),
but the mechanisms conveying their variable effectiveness are not known. Recent data …
but the mechanisms conveying their variable effectiveness are not known. Recent data …
[HTML][HTML] Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation
BACKGROUND Genomic and experimental studies suggest a role for PITX2 in atrial
fibrillation (AF). To assess if this association is relevant for recurrent AF in patients, we tested …
fibrillation (AF). To assess if this association is relevant for recurrent AF in patients, we tested …
[HTML][HTML] ElectroMap: high-throughput open-source software for analysis and mapping of cardiac electrophysiology
The ability to record and analyse electrical behaviour across the heart using optical and
electrode mapping has revolutionised cardiac research. However, wider uptake of these …
electrode mapping has revolutionised cardiac research. However, wider uptake of these …
[HTML][HTML] Novel regulation of cardiac Na pump via phospholemman
As the only quantitatively significant Na efflux pathway from cardiac cells, the Na/K ATPase (Na
pump) is the primary regulator of intracellular Na. The transmembrane Na gradient it …
pump) is the primary regulator of intracellular Na. The transmembrane Na gradient it …